We teamed up with newsrooms in other countries to delve into Mundipharma ... opioid sales abroad At home in the United States, Purdue Pharma, the drugmaker accused of fueling the opioid crisis ...

Though Purdue Pharma still sells opioids in the United ... The figure includes five European countries and is dominated by the United Kingdom and France; it excludes Germany and other countries ...

Purdue Pharma’s owners from the Sackler family have struck a new $6.5 billion settlement of mass litigation alleging they fueled addiction, reopening a path to end the longest and costliest ...

Purdue Pharma’s Sackler family owners are offering to increase their financial contribution to a bankruptcy settlement of opioid lawsuits while accepting some exposure to future litigation ...

The Sacklers and Purdue Pharma boosted their settlement contribution to $7.4 billion after the U.S. Supreme Court overturned a prior settlement in June 2024. If approved, the new plan would end ...

Purdue Pharma has filed a new bankruptcy plan as part of a $7.4 billion settlement to resolve thousands of lawsuits over the company’s alleged role in the opioid crisis, months after the Supreme ...

Global consulting firm McKinsey & Company agreed Friday to pay $650 million to resolve criminal and civil investigations into the advice it provided to opioids manufacturer Purdue Pharma.

McKinsey is an international consulting firm based in New York with offices in more than 65 countries and 135 cities ... for our past client service to Purdue Pharma and the actions of a former ...

The Sackler family and Purdue Pharma, the maker of the addictive painkiller oxycontin, have reached a $7.4 billion settlement with a bipartisan coalition of 15 states for fueling the opioid crisis ...

NEW YORK — Purdue Pharma and its Sackler family owners have reached a new $7.4 billion settlement to resolve thousands of lawsuits alleging that the pain medication OxyContin caused a widespread ...

NEW YORK, Oct 31 (Reuters) - Purdue Pharma is close to a new bankruptcy settlement with its owners, members of the wealthy Sackler family, and state and local governments that have filed lawsuits ...

NEW YORK, Sept 5 (Reuters) - Purdue Pharma on Thursday received an 18-day extension of a years-long pause on litigation against its owners, members of the wealthy Sackler family, after convincing ...